MIRA University of Twente
Scientists & UsersFor the scientific audience Industry & EconomyOpportunities for collaboration Public & MediaTop technology for patients Students & EducationLearn about the Master programmes


27 Nov 2015 - ‘Pioneers in Health Care Innovation vouchers’ awarded Medical Spectrum Twente (MST), the Twente Hospital Group (ZGT) and the University of Twente (UT) are partners in the ‘Pioneers in Health Care Innovation Fund’, which has now entered its second year. The health insurer Menzis is a new partner in the fund. The aim of the fund is to encourage collaboration between MST and ZGT medical specialists and researchers from UT’s MIRA research institute. These collaborative efforts are intended to result in new insights and technology that will serve to improve the effectiveness of patient care. 20 Nov 2015 - Researchers create functioning biological kidney tubule Researchers at Utrecht University, Radboudumc and the University of Twente succeeded in creating a functioning biological ‘kidney tubule’. The tubule was made from living kidney tissue grafted to a dialysis membrane. This allows to excrete waste products from the blood that normal dialysis cannot remove. “We hope that this combination will eventually be able to replace the current dialysis technique”, according to Utrecht University Prof. Roos Masereew. The results of their research have recently been published in Scientific Reports on 16 November. 30 Sep 2015 - Medical Tour Photoacoustics & Ultrasound This week, a delegation of 18 scientists, clinicians, and business people affiliated with the Center for Medical Imaging CMINEN are visiting Canada and the USA. The delegates are comprised of researchers and educational staff from University of Twente and Radboudumc, clinicians from Medisch Spectrum Twente, Ziekenhuisgroep Twente and Radboudumc, and representatives of various imaging companies and entrepreneurs in innovative medical imaging. 29 Sep 2015 - UT desalination chip should increase efficiency of medicine development Susan Roelofs, researcher with the UT research institutes MESA+ and MIRA, has developed a chip that should support the faster and cheaper marketing of new medicines. Her chip should make sure that the pharmaceutical industry can improve the analysis preparation of solutions containing candicate compounds for potential medicine. The chip removes the salt from the solution so that the solution can be analyzed. By scaling down an existing desalination technique to a chip it should be possible to strongly reduce the necessary amount of liquid containing the (expensive) potential medicine compounds. Roelofs will be awarded a doctorate for this research on 30 September at the University of Twente. Next she will research in a technical and financial feasibility research what possibilities there are to market the desalination chip. 24 Sep 2015 - University of Twente online: Ultrasound Imaging The Technical Medicine programme at the University of Twente offers a free online course starting 5 October: “Ultrasound Imaging: What is inside?” The course explains the technology of ultrasound, how it is used in a medical environment and how an understanding of the underlying technology will help improve patient care. "Ultrasound is used by many different medical professionals. The become even more valuable if they understand the technology behind the device," explains Wiendelt Steenbergen, Professor in Biomedical Photonic Imaging at the UT and senior lecturer of the course.
21 Sep 2015 - University of Twente enters into a 1,7 million Euro collaboration on health economics of personalized medicine and molecular diagnostics The HTSR research group of the research institute MIRA (University of Twente), the Luxembourg Institute of Health (LIH) and the University of York have just signed an international research collaboration investigating the clinical and economic challenges of personalized medicine. Personalized or precision medicine is the paradigm of targeting treatment to those that are likely to benefit from treatment and is a respons to the largely one size-fits all treatment approaches dominating medicine until now. The main clinical application of personalized medicine is oncology, followed by diabetes, cardio-vascular and rheumatic diseases. The 1,7 MEuro budget for four years should leverage external funding to strenghten capacity building in the field of personalized medicine in Luxembourg. The agreement includes recruitment of PhD’s, post-docs, and involves several staff in Luxembourg, York and Twente says Prof. IJzerman who is the principal investigator in Twente.    21 Sep 2015 - Desirable and undesirable variation in cancer care Care for cancer patients varies between hospitals. This means that the care provided depends on the hospital in which a person happens to be treated and this is not desirable. At the same time our knowledge about cancer is increasing and with new technologies we want to offer more personalized care . This would results in more desirable variation in cancer care. Professor dr. Sabine Siesling of the University of Twente (Health Technology & Services Research department) and senior researcher at the Netherlands Comprehensive Cancer Organization (IKNL), is investigating whether variation affects the quality and outcomes of care. Siesling will hold her inaugural lecture on the 24th of September.
31 Aug 2015 - Maaike Koenrades wins TGS award 2015 The TGS Research Honours PhD Award for Twente Doctoral Top Talent 2015 has been won by Maaike Koenrades, researcher at the Faculty of Science and Technology. She accepted the Award on Monday 31 August during the Opening of the Academic Year of the University of Twente. The prize awarded to Maaike Koenrades consists of a cheque of 2,500 euros, which she may spend on an educational programme or exchange during her doctoral research.